Oriol Bestard

Trackyourmed (Global Health-Tech Systems SL) is a digital health and biotechnology company founded by Dr. Oriol Bestard, a prominent expert in transplant nephrology. The company's flagship product is a mobile health platform designed to improve medication adherence in chronic patients, specifically those who have undergone organ transplantation. The platform utilizes a QR code-scanning system to verify medication intake and provides real-time monitoring for clinicians to optimize therapeutic management and reduce the risk of graft rejection. Additionally, the company's research team is developing Duacept, a novel bi-specific fusion protein currently in the pre-clinical stage, aimed at providing a second-generation immunosuppressive therapy with fewer side effects than current standards of care.